NDC 73377-019 - Dorzolamide Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-019
- Package NDCs from labels
- 73377-019-01, 73377-019-02
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2020-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dorzolamide Hydrochloride - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2020-09-16 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-019-01 | Dorzolamide Hydrochloride | 50 g in 1 JAR | POWDER | 50 | 2 | |
| 73377-019-02 | Dorzolamide Hydrochloride | 100 g in 1 JAR | POWDER | 100 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dorzolamide Hydrochloride and Timolol Maleate | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | A-S Medication Solutions | 8cdf22c8-75ca-404e-b354-9e254690d0e7 | 2024-11-01 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride | DORZOLAMIDE | Indoco Remedies Limited | 462a61b2-1ec6-4d18-bc6b-fc03e027caa0 | 2024-10-04 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Micro Labs Limited | f45cce05-fb47-4607-b68e-5a3d47e7235a | 2024-09-26 | Warnings, Adverse reactions | QZO5366EW7 |
| DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Somerset Therapeutics, LLC | 17f04726-725f-4839-911d-47fc5e02baae | 2024-09-18 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 5ad43fd4-19f0-448f-97a8-625ada4cb147 | 2024-08-27 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | fb2e0729-b0bc-4c3f-9961-8bb38f84a032 | 2024-08-27 | Warnings, Adverse reactions | QZO5366EW7 |
| DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE | Bryant Ranch Prepack | cfdc5577-fe7a-4b51-b2f5-95806e1dee2d | 2024-08-20 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide and Timolol | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION | Leading Pharma, LLC | c9ae08c5-275d-44b3-9d1e-5d8fedc21b96 | 2024-05-25 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Leading Pharma, LLC | 7d4cb6cd-86d0-41d9-baa9-bca0fa7b0694 | 2024-05-24 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Gland Pharma Limited | efab039e-a69d-4306-8305-b1d27781cfe0 | 2024-05-14 | Warnings, Adverse reactions | QZO5366EW7 |
| COSOPT | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Thea Pharma Inc. | 23bdf1c1-3134-4ad1-8e7c-bc655156bdc6 | 2024-04-17 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride Ophthalmic | DORZOLAMIDE HYDROCHLORIDE | A-S Medication Solutions | fa4b8802-3271-48a4-8a91-229ebc72f570 | 2023-12-15 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Bryant Ranch Prepack | be8b1a47-3342-4072-b67c-6d1374d5d4d6 | 2023-12-07 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide hydrochloride and timolol maleate | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Ingenus Pharmaceuticals, LLC | 36c0e765-dfda-4b3b-8a98-a5f8b32607f7 | 2023-08-02 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Bausch & Lomb Incorporated | 7f6ab3f6-3644-434c-b6cf-e4f111d18962 | 2023-06-23 | Warnings, Adverse reactions | QZO5366EW7 |
| DORZOLAMIDE HYDROCHLORIDE | DORZOLAMIDE HYDROCHLORIDE | Sandoz Inc | 29157995-fa61-4425-86a5-5bd0e4718cd8 | 2022-12-20 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Sandoz Inc | 78f39126-3e3b-4633-a4e0-c1f09a794eec | 2021-05-31 | Warnings, Adverse reactions | QZO5366EW7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.